Trial of Paclitaxel, Bevacizumab, and Enzastaurin Versus Paclitaxel, Bevacizumab and Placebo for Breast Cancer

NCT00536939 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped Study has been terminated due to slow enrollment

Conditions

Breast Cancer

Interventions

DRUG: Enzastaurin
DRUG: Bevacizumab
DRUG: Paclitaxel
DRUG: Placebo

Sponsor

Eli Lilly and Company

Collaborators

[object Object]